There are sufficient numbers in both treated arms, especially if the signals are strong. The subgroup analysis will likely identify that 50mg is better than 30mg, in general, but especially for the genetic variants. Missling stated there weren't major differences in therapeutic benefit between the two doses. Likely why the TLD data was aggregated.
The results of the genetic data and subgroup analysis will further develop their "precision medicine" targets.
Market Data 
Markets 
AI
